The nation of Zimbabwe has rejected a major US healthcare agreement valued at $367m (£272m) over five years because of the United States' demand for confidential biological samples.
The decision was revealed after a official document dated December was leaked, revealing that President Emmerson Mnangagwa felt the arrangement was "lopsided".
A government spokesman has since clarified that the US was seeking health data for research and commercial gain but was not willing to share the benefits from future treatments.
"We are forced to start the difficult and regrettable process of ending our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy said the United States had donated more than $1.9bn in health funding to Zimbabwe over the last two decades.
A medical body in Zimbabwe has called for continued talks to find a deal agreeable to all parties so the country's vital HIV treatment initiative can continue.
Broader Context
This development follows a similar situation in neighbouring Kenya, where a court suspended a related health funding agreement following concerns were raised about the safety of citizens' medical information.
Since resuming the presidency recently, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
USAID had overseen aid for the American government, but Trump claimed its spending was "inefficient" and his administration was pursuing government-to-government deals to enhance transparency and responsibility.
According to reports, Sixteen African countries have to date signed these new health pacts, constituting more than $18.3bn of fresh investment.
Details of the Declined Deal
This assistance for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this cooperation could have provided immense advantages for Zimbabwean communities, particularly the 1.2 million presently on antiretroviral therapy via US-supported initiatives," the Ambassador commented.
However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".
"Zimbabwe was being asked to share its biological resources and data over an extended period, without any corresponding guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," he stated.
"Effectively, our country would provide the basic resources for scientific discovery without any certainty that the end products would be accessible to our people if a future disease outbreak emerge."
National Interest and International Frameworks
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were undermining structures already established via the international health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing framework designed to manage future global health emergencies.
"This system is intended to guarantee that when a country contributes its information, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the capability to create them."
These objections over the US deal "must not be interpreted as opposition to America," he added.
"We are open to ongoing discussions with our US partners on how subsequent collaboration might be designed in a manner that honours the independence and interests of both nations."
Health Experts Reaction
Medical experts stated it recognised the government's concerns, but recommended that negotiations need to persist considering a large portion of the nation's HIV programmes relied on external financing.
"Where specific concerns exist, including those relating to information security or implementation frameworks, these can often be addressed via technical clarification and mutually agreed protections," it commented.
The situation underscores the ongoing challenges between receiving crucial international aid and protecting national sovereignty in an increasingly data-driven world.